Minimal Residual Disease Detection and Evolved IGH Clones Analysis in Acute B Lymphoblastic Leukemia Using IGH Deep Sequencing

Acute B lymphoblastic leukemia (B-ALL) is one of the most common types of childhood cancer worldwide and chemotherapy is the main treatment approach. Despite good response rates to chemotherapy regiments, many patients eventually relapse and minimal residual disease (MRD) is the leading risk factor...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Front Immunol
Glavni autori: Wu, Jinghua, Jia, Shan, Wang, Changxi, Zhang, Wei, Liu, Sixi, Zeng, Xiaojing, Mai, Huirong, Yuan, Xiuli, Du, Yuanping, Wang, Xiaodong, Hong, Xueyu, Li, Xuemei, Wen, Feiqiu, Xu, Xun, Pan, Jianhua, Li, Changgang, Liu, Xiao
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2016
Teme:
Immunology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5048610/
https://ncbi.nlm.nih.gov/pubmed/27757113
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2016.00403
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items